We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Genetic Loci Link Plasma Lipid Levels to CVD Risk

By LabMedica International staff writers
Posted on 07 Oct 2019
A team of Finnish and international researchers utilized both genomics and lipidomics approaches to identify novel genetic variants associated with plasma levels of lipid species and linked these levels to cardiovascular disease (CVD) risk.

The lipidome refers to the totality of lipids in cells. More...
The human plasma lipidome consists of almost 600 distinct molecular species. Research results have suggested that the lipidome of an individual may be able to indicate cancer risks associated with dietary fats, particularly breast cancer.

While some plasma lipids such as cholesterol and triglycerides are well-established heritable risk factors for CVD, hundreds of other lipid species are known risk factors for cardiovascular disease but have not been well characterized. In this regard, investigators at the University of Helsinki (Finland) and their collaborators sought to establish links between lipid levels and cardiovascular disease risk. Specifically, they aimed to (1) determine heritability of lipid species and their genetic correlations; (2) identify genetic variants influencing the plasma levels of lipid species; (3) test the relationship between identified lipid–species-associated variants and CVD manifestations and (4) gain mechanistic insights into established lipid variants.

For this study, they performed genome-wide association analyses of 141 lipid species (in 2,181 individuals), followed by phenome-wide scans with 25 CVD related phenotypes of 511,700 individuals.

Results showed that the scans had identified 35 lipid-species-associated loci, 10 of which associated with CVD risk including five new loci. Furthermore, they found that lipoprotein lipase (LPL) more efficiently hydrolyzed medium length triacylglycerides (TAGs) than others. Polyunsaturated lipids had the highest heritability and genetic correlations, suggesting considerable genetic regulation at fatty acids levels.

"Our study demonstrates that lipidomics enables much deeper insights into the genetic regulation of lipid metabolism. We hope that the openly available browser will in part help future biomarker and drug target discovery and build our understanding of the pathways connecting genetic variation to cardiovascular and other lipid-related diseases", said senior author Dr. Samuli Ripatti, professor of biometry at the University of Helsinki.

The study was published in the September 24, 2019, online edition of the journal Nature Communications and the data are freely available on the Internet at https://mqtl.fimm.fi.

Related Links:
University of Helsinki


Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Serological Pipet Controller
PIPETBOY GENIUS
New
Biochemistry Analyzer
Chemi+ 8100
New
Plasmodium Test
Plasmodium DNA Real Time PCR Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Non-coding RNAs CBR3-AS1 and PCA3 can be utilized as therapeutic targets and prognostic biomarkers in gastric cancer (Photo courtesy of Adobe Stock)

Promising Molecular Markers Support Earlier Diagnosis of Gastric Cancer

Late detection continues to make gastric cancer one of the leading causes of cancer-related deaths globally. With improved early detection tools urgently needed, researchers have now identified two long... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: Microscopy image of invasive breast cancer cells degrading their underlying extracellular matrix (Photo courtesy of University of Turku)

Visualization Tool Illuminates Breast Cancer Cell Migration to Suggest New Treatment Avenues

Patients with breast cancer who progress from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) face a significantly worse prognosis, as metastatic disease remains incurable.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.